13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC
ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 23 holding rows worth $325,815,708.
- Accession
- 0001085146-23-004496
- Filer
- CIK 1012622
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 23 entries on the cover page, a total value of $325,815,708 stated on the cover page (in dollars after the unit check, H1), rows summing to $325,815,708 with VALUE read as dollars as filed, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| QUIDELORTHO CORP | 219798905 | CALL | 1,870,000 | $136,584,800 | dollars as filed | call |
| PACIFIC BIOSCIENCES CALIF IN | 69404D908 | COM | 9,093,000 | $75,926,550 | dollars as filed | call |
| BIOHAVEN LTD | G1110E907 | COM | 1,573,000 | $40,913,730 | dollars as filed | call |
| BIOHAVEN LTD | G1110E107 | COM | 607,527 | $15,801,777 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 191,244 | $13,968,462 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,638,395 | $13,680,598 | dollars as filed | |
| QUIDELORTHO CORP | 219798955 | PUT | 100,000 | $7,304,000 | dollars as filed | put |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 555,522 | $3,933,096 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 994,580 | $3,620,271 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 749,700 | $3,058,776 | dollars as filed | |
| FORIAN INC | 34630N106 | cs | 1,368,067 | $3,050,926 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 2,116,963 | $2,392,168 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 300,000 | $1,239,000 | dollars as filed | |
| IMMUTEP LTD | 45257L108 | SPONSORED ADS | 516,430 | $981,217 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 485,886 | $835,724 | dollars as filed | |
| ACCELERATE DIAGNOSTICS INC | 00430H201 | COM | 136,528 | $785,036 | dollars as filed | |
| OPKO HEALTH INC | 68375N103 | COM | 450,564 | $720,902 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 2,412 | $619,908 | dollars as filed | |
| VERTEX ENERGY INC | 92534K107 | COM | 25,300 | $112,585 | dollars as filed | |
| OMEGA THERAPEUTICS INC | 68217N105 | COMMON STOCK | 50,000 | $107,500 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 42,076 | $69,425 | dollars as filed | |
| DERMTECH INC | 24984K105 | COM | 47,687 | $68,669 | dollars as filed | |
| INKT | 603693102 | Stock | 36,898 | $40,588 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-23-004496 | this filing | 2023-11-14 | acceptance time not in the bulk data set |